Auditor - GCP

Audit Execution

Coverage of assigned external audits of clinical investigator sites, Contract Research Organizations (CROs), E-System providers, and Institutional Review Boards (IRBs/ECs).

Reporting & Risk Categorization

Development and issuance of comprehensive Audit Reports, categorizing findings by risk level and providing recommendations for corrective and preventive actions (CAPA) related to trial conduct and data integrity.

Trend Analysis

Identification of non-compliance trends and systematic risks within the Clinical (GCP) discipline, communication of findings to line management and clinical functional leads to ensure trial robustness.

Continuous Improvement

Support of initiatives to improve standard operating procedures (SOPs) for audit conduct and partnership with stakeholders to develop risk-based, compliant solutions for clinical trial management and monitoring.

Regulatory Knowledge

Maintenance of up-to-date knowledge of global GCP regulations (ICH E6) and industry trends, identification of new requirements to ensure a high level of quality is maintained across all clinical development programs.

Skills And Experience

• Academic Background: BS degree in a relevant biological science, science, or related discipline

• Professional Experience: 3+ years of Quality Assurance experience within a GCP-regulated environment, demonstrating a strong understanding of clinical trial phases, monitoring, and regulatory frameworks

• Audit Expertise: Experience in clinical audit and inspection management, with a clear understanding of the requirements for quality assurance in the clinical research discipline

• Communication Skills: Excellent interpersonal and negotiation skills, with the ability to work effectively with multinational clinical teams, investigators, and external CROs

• Working Knowledge of:

  • ICH E6 (R3) Guideline
  • 21 CFR Part 11 – Electronic Records; Electronic Signatures
  • 21 CFR Part 50 – Protection of Human Subjects (Informed Consent)
  • 21 CFR Part 312 – Investigational New Drug Application
  • 21 CFR Part 812 – Investigational Device Exemptions
  • Clinical Trials Regulation (CTR) (EU) No 536/2014
  • Directive 2001/20/EC (Clinical Trial Directive)
  • Directive 2005/28/EC (GCP Directive)
  • Directive 2001/83/EC (Annex I)
  • Directive 2001/83/EC (Annex I)

• Organizational Agility: Strong analytical and problem-solving skills, with the ability to work with limited supervision and manage a schedule that includes up to 50% travel